Antibody-mediated targeting of replication-competent retroviral vectors

Human Gene Therapy

Volumn 14, Issue 8, 2003, Pages 789-802

  Tai, Chien Kuo ^a   Logg, Christopher R ^a   Park, Jinha M ^a   Anderson, W French ^a   Press, Michael F ^a   Kasahara, Noriyuki ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; PROTEIN A; RETROVIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; ONCOGENE NEU; PROTEIN DOMAIN; SOLID TUMOR; TANDEM REPEAT; VIRION; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; DNA, VIRAL; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; KINETICS; LEUKEMIA VIRUS, MURINE; LUMINESCENT PROTEINS; MICE; NIH 3T3 CELLS; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; STAPHYLOCOCCAL PROTEIN A; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS REPLICATION;

ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0038021046     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403765255174     Document Type: Article

References (43)

1. ALBRITTON, L.M., TSENG, L., SCADDEN, D., and CUNNINGHAM, J.M. (1989). A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57, 659-666.
2. BENEDICT, C.A., MACKRELL, A.J., and ANDERSON, W.F. (1997). Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay. J. Immunol. Methods 201, 223-231.
3. BENEDICT, C.A., TUN, R.Y., RUBINSTEIN, D.B., GUILLAUME, T., CANNON, P.M., and ANDERSON, W.F. (1999). Targeting retroviral vectors to CD34-expressing cells: Binding to CD34 does not catalyze virus-cell fusion. Hum. Gene Ther. 10, 545-557.
4. BOIVIN, G., COULOMBE, Z., and RIVEST, S. (2002). Intranasal herpes simplex virus type 2 inoculation causes a profound thymidine kinase dependent cerebral inflammatory response in the mouse hindbrain. Eur. J. Neurosci. 16, 29-43.
5. BORG, J.P., MARCHETTO, S., LE BIVIC, A., OLLENDORFF, V., JAULIN-BASTARD, F., SAITO, H., FOURNIER, E., ADELAIDE, J., MARGOLIS, B., and BIRNBAUM, D. (2000). ERBIN: A basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nat. Cell. Biol. 2, 407-414.
6. CARRAWAY, K.L., 3rd, and SWEENEY, C. (2001). Localization and modulation of ErbB receptor tyrosine kinases. Curr. Opin. Cell. Biol. 13, 125-130.
7. CHU, T.H., and DORNBURG, R. (1995). Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J. Virol. 69, 2659-2663.
8. CHU, T.H., and DORNBURG, R. (1997). Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies. J. Virol. 71, 720-725.
9. DI FIORE, P.P., PIERCE, J.H., KRAUS, M.H., SEGATTO, O., KING, C.R., and AARONSON, S.A. (1987). erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237, 178-182.
10. DUBRIDGE, R.B., TANG, P., HSIA, H.C., LEONG, P.M., MILLER, J.H., and CALOS, M.P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379-387.
11. EVANS, L.H., MORRISON, R.P., MALIK, F.G., PORTIS, J., and BRITT, W.J. (1990). A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 64, 6176-6183.
12. FALCIONI, R., ANTONINI, A., NISTICO, P., DI STEFANO, S., CRESCENZI, M., NATALI, P.G., and SACCHI, A. (1997). Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp. Cell Res. 236, 76-85.
13. FOSTER, B.J., and KERN, J.A. (1997). HER2-targeted gene transfer. Hum. Gene Ther. 8, 719-727.
14. GELINAS, C., and TEMIN, H.M. (1986). Nondefective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses. Proc. Natl. Acad. Sci. U.S.A. 83, 9211-9215.
15. JAINCHILL, J.L., AARONSON, S.A., and TODARO, G.J. (1969). Murine sarcoma and leukemia viruses: Assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4, 549-553.
16. JAULIN-BASTARD, F., SAITO, H., LE BIVIC, A., OLLENDORFF, V., MARCHETTO, S., BIRNBAUM, D., and BORG, J.P. (2001). The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins. J. Biol. Chem. 276, 15256-15263.
17. JOSEPH, D.R. (1981). Efficient production of xenotropic murine leukemia virus unintegrated proviral DNA by cocultivation. J. Virol. 38, 1095-1098.
18. KADAN, M.J., STURM, S., ANDERSON, W.F., and EGLITIS, M.A. (1992). Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J. Virol. 66, 2281-2287.
19. KASAHARA, N., DOZY, A.M., and KAN, Y.W. (1994). Tissue-specific targeting of retroviral vectors through ligand-receptor interactions [see comments]. Science 266, 1373-1376.
20. KAYMAN, S.C., PARK, H., SAXON, M., and PINTER, A. (1999). The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system. J. Virol. 73, 1802-1808.
21. LAVILLETTE, D., BOSON, B., RUSSELL, S.J., and COSSET, F.L. (2001 a). Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. J. Virol. 75, 3685-3695.
22. LAVILLETTE, D., RUSSELL, S.J., and COSSET, F.L. (2001b). Retargeting gene delivery using surface-engineered retroviral vector particles. Curr. Opin. Biotechnol. 12, 461-466.
23. LOGG, C.R., LOGG, A., TAI, C.K., CANNON, P.M., and KASAHARA, N. (2001a). Genomic stability of routine leukemia viruses containing insertions at the Env-3′ untranslated region boundary. J. Virol. 75, 6989-6998.
24. LOGG, C.R., TAI, C.K., LOGG, A., ANDERSON, W.F., and KASAHARA, N. (2001b). A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors. Hum. Gene Ther. 12, 921-932.
25. LOGG, C.R., LOGG, A., MATUSIK, R.J., BOCHNER, B.H., and KASAHARA, N. (2002). Tissue-specific transcriptional targeting of a replication-competent retroviral vector. J. Virol. 76, 12783-12791.
26. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
27. MILLER, D.G., EDWARDS, R.H., and MILLER, A.D. (1994). Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc. Natl. Acad. Sci. U.S.A. 91, 78-82.
28. MORIZONO, K., BRISTOL, G., XIE, Y.M., KUNG, S.K., and CHEN, I.S. (2001). Antibody-directed targeting of retroviral vectors via cell surface antigens. J. Virol. 75, 8016-8020.
29. NILSSON, B., MOKS, T., JANSSON, B., ABRAHMSEN, L., ELMBLAD, A., HOLMGREN, E., HENRICHSON, C., JONES, T.A., and UHLEN, M. (1987). A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng. 1, 107-113.
30. OHNO, K., and MERUELO, D. (1997). Retrovirus vectors displaying the IgG-binding domain of protein A. Biochem. Mol. Med. 62, 123-127.
31. OHNO, K., SAWAI, K., IIJIMA, Y., LEVIN, B., and MERUELO, D. (1997). Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat. Biotechnol. 15, 763-767.
32. PARK, J.M., YANG, X., PARK, J.J., PRESS, O.W., and PRESS, M.F. (1999). Assessment of novel anti-p185HER-2 monoclonal antibodies for internalization-dependent therapies. Hybridoma 18, 487-495.
33. PEAR, W.S., NOLAN, G.P., SCOTT, M.L., and BALTIMORE, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 90, 8392-8396.
34. RUSSELL, S.J., HAWKINS, R.E., and WINTER, G. (1993). Retroviral vectors displaying functional antibody fragments. Nucl. Acids Res. 21, 1081-1085.
35. SOMIA, N.V., ZOPPE, M., and VERMA, I.M. (1995). Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc. Natl. Acad. Sci. U.S.A. 92, 7570-7574.
36. STEIN, I., ITIN, A., EINAT, P., SKALITER, R., GROSSMAN, Z., and KESHET, E. (1998). Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia. Mol. Cell. Biol. 18, 3112-3119.
37. VALSESIA-WITTMANN, S. (2001). Role of chimeric routine leukemia virus env beta-turn polyproline spacers in receptor cooperation. J. Virol. 75, 8478-8486.
38. VALSESIA-WITTMANN, S., DRYNDA, A., DELEAGE, G., AUMAILLEY, M., HEARD, J.M., DANOS, O., VERDIER, G., and COSSET, F.L. (1994). Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J. Virol. 68, 4609-4619.
39. VAN ZEIJL, M., JOHANN, S.V., CLOSS, E., CUNNINGHAM, J., EDDY, R., SHOWS, T.B., and O'HARA, B. (1994). A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc. Natl. Acad. Sci. U.S.A. 91, 1168-1172.
40. WEBER, E., ANDERSON, W.F., and KASAHARA, N. (2001). Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks. Curr. Opin. Mol. Ther. 3, 439-453.
41. WEIMIN WU, B., CANNON, P.M., GORDON, E.M., HALL, F.L., and ANDERSON, W.F. (1998). Characterization of the proline-rich region of murine leukemia virus envelope protein. J. Virol. 72, 5383-5391.
42. WILSON, J.M. (1996). Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334, 1185-1187.
43. ZHAO, Y., ZHU, L., LEE, S., LI, L., CHANG, E., SOONG, N.W., DOUER, D., and ANDERSON, W.F. (1999). Identification of the block in targeted retroviral-mediated gene transfer. Proc. Natl. Acad. Sci. U.S.A. 96, 4005-4010.